Stem Cell and Transplantation Biology
Stem Cell and Transplantation Biology
批准号:
10472478
负责人:
DEREK L STIREWALT
金额:
$63.28万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-01 至 2026-07-31
关键词:
AddressAdherenceAdvisory CommitteesAnimal ModelAreaAwardBiological AssayBiological ProductsBiologyBiomedical ResearchCD34 geneCanis familiarisCellsChargeChimerismCollaborationsCommunitiesConsultationsCountryDevelopmentDirect CostsDisease modelDoctor of PhilosophyDog DiseasesEducational workshopEnsureFacultyFee-for-Service PlansFred Hutchinson Cancer Research CenterFundingGene ExpressionGene-ModifiedGenesGoalsGrantHematological DiseaseHematologyHematopoiesisHumanIn VitroIncomeIndividualInstitutionInternshipsLiquid substanceLogisticsMeasurementMeasuresMediatingModelingNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNitrogenNon-MalignantPatientsPersonsPilot ProjectsPositioning AttributePre-Clinical ModelProceduresProcessProductionProtocols documentationPyruvate KinaseQuality ControlResearchResearch PersonnelResourcesScienceServicesShippingShipsSiteSpeedSpumavirusStem cell transplantTrainingTransplantationTravelUnderrepresented PopulationsUnderrepresented StudentsUnderserved PopulationUniversitiesViralWashingtonWorkXenograft procedurebasecanine modelcostcost effectivedata sharingdesignexperiencegene therapygenetic manipulationgraft vs host diseasein vivoin vivo Modelin vivo evaluationmembernew technologynovel therapeuticsonline communityorganizational structureoutcome predictionpre-clinicalpreventprogramsquality assuranceranpirnaserecruitsafety outcomesstemstem cellstooltransplant modeltransplantation therapytreatment responsevirtualweb site
中文摘要
项目摘要/摘要-总体
英文摘要
PROJECT SUMMARY/ABSTRACT - Overall
The theme of this CCEH is focused on stem cell and transplantation biology. The aims are designed to
overcome obstacles that prevent new investigators from joining this field. Specifically the four cores will
provide investigators access to: Large numbers of human and canine stem/progenitor cells; Scalable viral
production services for AAV, gamma-, lenti- and foamy viruses; Products for precision gene editing and
functional genetic manipulation; PCR assays for tracking chimerism, and insertion sites; Xenografting to
assess human hematopoiesis; Large animal model for preclinical in vivo testing and disease modeling.
The major goal of this CCEH is to make these services available throughout the US. For this purpose,
products and services must be cost- effective and of high quality. Also training in best practices for the use
of these resources is imperative. Towards this goal core staff provide on-site training: funds to support travel
to attend training sessions are available. In addition, standard operating procedures (SOP) and quality
control measures (QC) for all processes and products are shared on our website where they can be
discussed and amended as the science evolves.
The logistics of distributing products throughout the country are challenging. However, since the first
iteration of this grant (P30 DK056465) in 1999 we have successfully shipped highly purified CD34 cells in
liquid nitrogen to hundreds of satisfied investigators. Our costs are generally less than 1/3 of the cheapest
commercial vender, and our product is better. Logistics for shipping other biological products to out of state
users are already in place.
The fees for service charged by this CCEH generates program income of $1-2 million per year. These funds
are used to increase staff, develop new technologies and to fund the Enrichment Program. The goal is to
help build a strong, diverse, interactive hematology research community. Included in this effort is a research
internship program for students from underrepresented or underserved populations.
The Seattle CCEH research base consists of 25 faculty members at the University of Washington and/or the
Fred Hutchinson Cancer Research Center. Currently our research base brings in $17,130,946 in direct costs
per year for studies in non-malignant hematopoiesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
-
批准号:9899941
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2016
-
负责人:DEREK L STIREWALT
-
依托单位:
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
-
批准号:9105139
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2016
-
负责人:DEREK L STIREWALT
-
依托单位:
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
-
批准号:9452035
-
项目类别:
-
资助金额:$58.03万
-
财政年份:2016
-
负责人:DEREK L STIREWALT
-
依托单位:
Cell Procurement & Processing
-
批准号:10207253
-
项目类别:
-
资助金额:$15.42万
-
财政年份:2015
-
负责人:DEREK L STIREWALT
-
依托单位:
Stem Cell and Transplantation Biology
-
批准号:10675711
-
项目类别:
-
资助金额:$63.28万
-
财政年份:2015
-
负责人:DEREK L STIREWALT
-
依托单位:
Cell Procurement & Processing
-
批准号:10675715
-
项目类别:
-
资助金额:$22.96万
-
财政年份:2015
-
负责人:DEREK L STIREWALT
-
依托单位:
Cell Procurement & Processing
-
批准号:10595863
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2015
-
负责人:DEREK L STIREWALT
-
依托单位:
Cell Procurement & Processing
-
批准号:10472481
-
项目类别:
-
资助金额:$22.96万
-
财政年份:2015
-
负责人:DEREK L STIREWALT
-
依托单位:
Discovery and Optimization of AML Prognostic Biomarkers
-
批准号:8625275
-
项目类别:
-
资助金额:$47.04万
-
财政年份:2012
-
负责人:DEREK L STIREWALT
-
依托单位:
Discovery and Optimization of AML Prognostic Biomarkers
-
批准号:9024460
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2012
-
负责人:DEREK L STIREWALT
-
依托单位:
Discovery and Optimization of AML Prognostic Biomarkers
-
批准号:8464673
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2012
-
负责人:DEREK L STIREWALT
-
依托单位:
Discovery and Optimization of AML Prognostic Biomarkers
-
批准号:8296160
-
项目类别:
-
资助金额:$59.73万
-
财政年份:2012
-
负责人:DEREK L STIREWALT
-
依托单位:
IRF8 as a Biomarker of Aging, Malignant Transformation, and AML Prognosis
-
批准号:8006437
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2009
-
负责人:DEREK L STIREWALT
-
依托单位:
IRF8 as a Biomarker of Aging, Malignant Transformation, and AML Prognosis
-
批准号:7788239
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2009
-
负责人:DEREK L STIREWALT
-
依托单位:
Quantitative RT/PCR-based radiation dosimetry
-
批准号:7055179
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2005
-
负责人:DEREK L STIREWALT
-
依托单位:
Examination of FLT3 Mutations in Acute Myeloid Leukemia
-
批准号:7074584
-
项目类别:
-
资助金额:$10.67万
-
财政年份:2002
-
负责人:DEREK L STIREWALT
-
依托单位:
Examination of FLT3 Mutations in Acute Myeloid Leukemia
-
批准号:6472559
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2002
-
负责人:DEREK L STIREWALT
-
依托单位:
Examination of FLT3 Mutations in Acute Myeloid Leukemia
-
批准号:6605868
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2002
-
负责人:DEREK L STIREWALT
-
依托单位:
Examination of FLT3 Mutations in Acute Myeloid Leukemia
-
批准号:6757981
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2002
-
负责人:DEREK L STIREWALT
-
依托单位:
Examination of FLT3 Mutations in Acute Myeloid Leukemia
-
批准号:6909895
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:DEREK L STIREWALT
-
依托单位:
海外基金